Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/28/2787342/0/en/Portage-Biotech-Reports-Results-for-Fiscal-Quarter-Ended-June-30-2023-and-Business-Update.html

WESTPORT, Conn., Nov. 28, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ:PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported financial results for the fiscal quarter ended September 30, 2023.

Read more at globenewswire.com

Related news for (PRTG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.